248 related articles for article (PubMed ID: 9722003)
21. Expression of metalloproteinases and tissue inhibitors of metalloproteinases in giant cell tumor of bone: an immunohistochemical study with clinical correlation.
Schoedel KE; Greco MA; Stetler-Stevenson WG; Ohori NP; Goswami S; Present D; Steiner GC
Hum Pathol; 1996 Nov; 27(11):1144-8. PubMed ID: 8912822
[TBL] [Abstract][Full Text] [Related]
22. Localization of matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 in normal human and rabbit stomachs.
Tatsuguchi A; Fukuda Y; Ishizaki M; Yamanaka N
Digestion; 1999; 60(3):246-54. PubMed ID: 10343138
[TBL] [Abstract][Full Text] [Related]
23. Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and their inhibitors with prognosis in cervical carcinoma.
Nuovo GJ; MacConnell PB; Simsir A; Valea F; French DL
Cancer Res; 1995 Jan; 55(2):267-75. PubMed ID: 7812956
[TBL] [Abstract][Full Text] [Related]
24. High levels of tissue inhibitor of metalloproteinase-1 predict poor outcome in patients with breast cancer.
McCarthy K; Maguire T; McGreal G; McDermott E; O'Higgins N; Duffy MJ
Int J Cancer; 1999 Feb; 84(1):44-8. PubMed ID: 9988231
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinases-2 and -9 are expressed in human neuroblastoma: contribution of stromal cells to their production and correlation with metastasis.
Sugiura Y; Shimada H; Seeger RC; Laug WE; DeClerck YA
Cancer Res; 1998 May; 58(10):2209-16. PubMed ID: 9605768
[TBL] [Abstract][Full Text] [Related]
26. Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone.
Bord S; Horner A; Hembry RM; Reynolds JJ; Compston JE
J Anat; 1997 Jul; 191 ( Pt 1)(Pt 1):39-48. PubMed ID: 9279657
[TBL] [Abstract][Full Text] [Related]
27. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas.
Iwata H; Kobayashi S; Iwase H; Masaoka A; Fujimoto N; Okada Y
Jpn J Cancer Res; 1996 Jun; 87(6):602-11. PubMed ID: 8766524
[TBL] [Abstract][Full Text] [Related]
28. Expression of immunoreactive matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in human normal livers and primary liver tumors.
Terada T; Okada Y; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1341-4. PubMed ID: 8675149
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.
Afzal S; Lalani el-N ; Foulkes WD; Boyce B; Tickle S; Cardillo MR; Baker T; Pignatelli M; Stamp GW
Lab Invest; 1996 Feb; 74(2):406-21. PubMed ID: 8780160
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta.
Huppertz B; Kertschanska S; Demir AY; Frank HG; Kaufmann P
Cell Tissue Res; 1998 Jan; 291(1):133-48. PubMed ID: 9394051
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
33. Tissue MMP-2 and MMP-9 [corrected] are better prognostic factors than serum MMP-2/TIMP-2--complex or TIMP-1 [corrected] in stage [corrected] I-III lung carcinoma.
Hoikkala S; Pääkkö P; Soini Y; Mäkitaro R; Kinnula V; Turpeenniemi-Hujanen T
Cancer Lett; 2006 May; 236(1):125-32. PubMed ID: 15982804
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of transforming growth factor-beta 1, matrix metalloproteinase-2,9, tissue inhibitors of metalloproteinase-1,2, and basement membrane components at pancreatic ducts in chronic pancreatitis.
Ishihara T; Hayasaka A; Yamaguchi T; Kondo F; Saisho H
Pancreas; 1998 Nov; 17(4):412-8. PubMed ID: 9821184
[TBL] [Abstract][Full Text] [Related]
35. Expression of MMP-2, -7, -9, MT1-MMP and TIMP-1 and -2 has no prognostic relevance in patients with advanced epithelial ovarian cancer.
Brun JL; Cortez A; Lesieur B; Uzan S; Rouzier R; Daraï E
Oncol Rep; 2012 Apr; 27(4):1049-57. PubMed ID: 22200690
[TBL] [Abstract][Full Text] [Related]
36. Cloning of murine membrane-type-1-matrix metalloproteinase (MT-1-MMP) and its metanephric developmental regulation with respect to MMP-2 and its inhibitor.
Ota K; Stetler-Stevenson WG; Yang Q; Kumar A; Wada J; Kashihara N; Wallner EI; Kanwar YS
Kidney Int; 1998 Jul; 54(1):131-42. PubMed ID: 9648071
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical study of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in pulmonary lymphangioleiomyomatosis (LAM).
Hayashi T; Fleming MV; Stetler-Stevenson WG; Liotta LA; Moss J; Ferrans VJ; Travis WD
Hum Pathol; 1997 Sep; 28(9):1071-8. PubMed ID: 9308732
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
39. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
40. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
